Naproxen Sodium Extended-Release Actual Use Study

Status:	Completed
Conditions:	Chronic Pain
Therapuetic Areas:	Musculoskeletal
Healthy:	No
Age Range:	12 - Any
Updated:	4/21/2016
Start Date:	July 2008
End Date:	November 2008

An Open Label, Actual Use Study in Consumers Taking an Extended-Release Over the Counter NSAID in a Naturalistic Setting

The purpose of this Study is to assess how subjects will use the investigational product in
an uncontrolled, naturalistic environment.

Issues on adverse event data are addressed in the Adverse Event section.

The following acronyms and abbreviations were used in the results section.

- General Educational Development (GED)

Inclusion Criteria:

- Self report use of Over The Counter (OTC) analgesics

- Able to read and understand English

- Provide written informed consent (subjects 12- 17 years of age provide written as
sent and/ or parent or legal guardian provide written consent)

- Purchase the investigational product

Exclusion Criteria:

- Have participated in a study involving OTC analgesics in the last 12 months

- They or someone else in the household work for a market research company, an
advertising agency, a public relations firm, pharmaceutical company, as a healthcare
professional, or as part of a health care practice

- Have a history of known allergies to nonsteroidal anti-inflammatory drugs (NSAIDs)
(i.e., Naproxen, Ibuprofen, etc) or Aspirin

- Have a history of heart surgery in the last 60 days or plans for heart surgery in the
next 60 days

- (Female subjects) are pregnant or breastfeeding

We found this trial at

sites

Clinical Trial Facility in Overland Park Kansas

Overland Park, Kansas

from

Overland Park, KS